ned, the contents must be used within two months. At temperatures below 68°F (20°C) the solution may gel; light flocculation or the formation of a light sediment may also occur. There is no impact on product performance or dosing using the syringe provided. Allow to warm to room temperature 77°F (25°C) to reverse these changes.
* Sandimmune® is a registered trademark of Novartis Pharmaceuticals Corporation.
©Abbott
Abbott Laboratories, North Chicago, IL 60064, U.S.A.
Rev. 06/2009
NDC 0074–7269–50
50 mL Gengraf® (Cyclosporine Oral Solution, USP [MODIFIED]) 100mg/mL
WARNING: Gengraf ® (cyclosporine oral solution, USP [MODIFIED]) is NOT BIOEQUIVALENT to Sandimmune®* (cyclosporine oral solution, USP). Do NOT use interchangeably without a physician’s supervision.
Each mL contains: Cyclosporine, USP...........100 mg
Abbott Laboratories Rx Only
NDC 0074–7269–50
Gengraf® (Cyclosporine Oral Solution, USP [MODIFIED]) 100mg/mL, 50mL
WARNING: Gengraf ® (cyclosporine oral solution, USP [MODIFIED]) is NOT BIOEQUIVALENT to Sandimmune®* (cyclosporine oral solution, USP). Do NOT use interchangeably without a physician’s supervision.
Rx Only
GENGRAF
cyclosporine solution |
|
|
|
|
|
|
|
|
